| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00868527 |
| P698 | PubMed publication ID | 8936360 |
| P50 | author | Rosaline Quinlivan | Q96301762 |
| P2093 | author name string | R M Quinlivan | |
| R A Hughes | |||
| P Choudhary | |||
| N Thompson | |||
| P2860 | cites work | Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy | Q33588840 |
| Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study | Q33590410 | ||
| Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases | Q33596381 | ||
| Cerebral vascular accidents in patients over the age of 60. II. Prognosis | Q34241339 | ||
| Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. | Q34253953 | ||
| Laboratory testing of muscle function in the management of neuromuscular disease | Q36936272 | ||
| Chronic idiopathic polyneuropathy treated with azathioprine | Q37026158 | ||
| Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin | Q40746921 | ||
| "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy | Q41380961 | ||
| Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement | Q43431737 | ||
| Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease | Q43839016 | ||
| Test-retest reliability of hand-held dynamometry during a single session of strength assessment | Q44576693 | ||
| Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome | Q44643471 | ||
| High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study | Q45361840 | ||
| Maximal isometric torque of knee extension as a function of muscle length in subjects of advancing age. | Q45390629 | ||
| High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy | Q46854866 | ||
| A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. | Q52882065 | ||
| Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests | Q67946424 | ||
| Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer | Q68379314 | ||
| Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy | Q68859537 | ||
| Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force | Q70147600 | ||
| Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment | Q70229274 | ||
| Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy | Q70410817 | ||
| Measuring muscle strength | Q70716150 | ||
| A study of the reproducibility of muscle testing and certain other aspects of muscle scoring | Q73507820 | ||
| Muscle testing. 2. Reliability in clinical use | Q78894698 | ||
| P433 | issue | 3 | |
| P921 | main subject | chronic inflammatory demyelinating polyradiculoneuropathy | Q1088030 |
| P304 | page(s) | 280-285 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy | |
| P478 | volume | 243 |
| Q37067680 | Assessing walking speed in clinical research: a systematic review |
| Q35512273 | Autoimmune neuromuscular disorders in childhood |
| Q37714082 | Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition |
| Q35449950 | Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies |
| Q33991742 | Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada |
| Q34330842 | Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study |
| Q37542243 | Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). |
| Q22252522 | Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification |
| Q49299297 | IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety |
| Q36164827 | IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results. |
| Q24201954 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24236599 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q36365583 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. |
| Q83226673 | Inflammatory demyelinating neuropathies |
| Q36332682 | Initial and long-term management of autoimmune neuropathies |
| Q24670327 | Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin |
| Q80454073 | Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial |
| Q24201573 | Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24240936 | Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q34699002 | Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. |
| Q35172375 | Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review |
| Q37891769 | Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. |
| Q34574581 | Intravenous immunoglobulin in neurological disease: a specialist review. |
| Q35048028 | Management of chronic inflammatory demyelinating polyradiculoneuropathy |
| Q37507924 | Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q92904400 | Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes |
| Q37125900 | Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial |
| Q24676037 | Systematic reviews of treatment for inflammatory demyelinating neuropathy |
| Q36100132 | Treatment of dys-immune neuropathies. |
| Q30397454 | Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. |
| Q35452109 | Use of human intravenous immunoglobulin in lower motor neuron syndromes |
| Q80953233 | [Immunomodulatory effects of intravenous immunoglobulins] |
| Q81317771 | [Intravenous immunoglobulins: therapeutic indications] |
| Q83179107 | [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies] |
| Q73507540 | [Therapeutic indications of intravenous immunoglobulins] |
Search more.